Changes in erythropoiesis-stimulating agent responsiveness after transfer to combined therapy with peritoneal dialysis and hemodialysis for patients on peritoneal dialysis: A prospective multicenter study in Japan.

Yukio MaruyamaKeitaro YokoyamaChieko HiguchiTsutomu SanakaYoshihide TanakaKen SakaiYoshihiko KannoMunekazu RyuzakiTsutomu SakuradaTatsuo HosoyaMasaaki Nakayamanull null

Published in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2023)

Although detailed mechanism was unclear, ESA responsiveness improved after switching from PD alone to combined therapy.

Keyphrases

peritoneal dialysis
end stage renal disease
chronic kidney disease
stem cells
prognostic factors
replacement therapy